المؤلفون: Asmus E; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Karle W; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Brack MC; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Wittig C; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Behrens F; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Reinshagen L; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.; Department of Cardiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Pfeiffer M; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Schulz S; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Mandzimba-Maloko B; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Erfinanda L; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Perret PL; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Michalick L; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany., Smeele PJ; Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands., Lim EHT; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Neurology, University of Amsterdam, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, The Netherlands., van den Brom CE; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Anesthesiology, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands., Vonk ABA; Department of Cardiothoracic Surgery, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands., Kaiser T; German Rheumatism Research Centre Berlin (DRFZ) - Flow Cytometry Core Facility, Berlin, Germany., Suttorp N; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Partner site Berlin, Berlin, Germany., Hippenstiel S; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Partner site Berlin, Berlin, Germany., Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Partner site Berlin, Berlin, Germany., Kurth F; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Partner site Berlin, Berlin, Germany., Rauch U; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.; Department of Cardiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Landmesser U; Berlin Institute of Health (BIH), Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.; Department of Cardiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Haghikia A; Berlin Institute of Health (BIH), Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.; Department of Cardiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Preissner R; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Science-IT, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Bogaard HJ; Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands., Witzenrath M; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Partner site Berlin, Berlin, Germany., Kuebler WM; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Partner site Berlin, Berlin, Germany.; The Keenan Research Centre for Biomedical Science at St. Michael's, Toronto, ON, Canada.; Departments of Surgery and Physiology, University of Toronto, Toronto, ON, Canada.; These authors contributed equally to this work., Szulcek R; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Department of Pulmonary Diseases, Amsterdam UMC, VU University Medical Center, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands.; German Heart Center Berlin, Berlin, Germany.; These authors contributed equally to this work., Simmons S; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany szandor.simmons@charite.de.; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.; These authors contributed equally to this work.

المصدر: The European respiratory journal [Eur Respir J] 2023 Mar 23; Vol. 61 (3). Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Cystic Fibrosis*, Humans ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; Health Status ; Platelet Activation ; Mutation

المؤلفون: de Brabander J; Amsterdam UMC, location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Amsterdam, The Netherlands j.debrabander@amsterdamumc.nl., Duijvelaar E; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Schippers JR; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Smeele PJ; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Peters-Sengers H; Amsterdam UMC, location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Amsterdam, The Netherlands., Duitman JW; Amsterdam UMC, location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.; Amsterdam UMC, location University of Amsterdam, Department of Experimental Immunology (EXIM), Amsterdam, The Netherlands., Aman J; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., Bogaard HJ; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., van der Poll T; Amsterdam UMC, location University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM), Amsterdam, The Netherlands., Bos LDJ; Amsterdam UMC, location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.; Amsterdam UMC, location University of Amsterdam, Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Amsterdam, The Netherlands.

مؤلفون مشاركون: CounterCOVID Study Group

المصدر: The European respiratory journal [Eur Respir J] 2022 Dec 15; Vol. 60 (6). Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022).

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/mortality , Imatinib Mesylate*/therapeutic use , Immunomodulation* , COVID-19 Drug Treatment*, Humans ; Biomarkers ; Pulmonary Surfactant-Associated Protein D

المؤلفون: Duijvelaar E; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and., Vanhove A; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and., Schippers JR; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and., Smeele PJ; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and., de Man FS; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and., Pinto Y; Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology., Aman J; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and., Bogaard HJ; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.

مؤلفون مشاركون: CounterCOVID Collaborative Group

المصدر: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2022 Dec 01; Vol. 80 (6), pp. 783-791. Date of Electronic Publication: 2022 Dec 01.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Electronic Cited Medium: Internet ISSN: 1533-4023 (Electronic) Linking ISSN: 01602446 NLM ISO Abbreviation: J Cardiovasc Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Cardiovascular Diseases*, Humans ; Imatinib Mesylate/adverse effects ; Stroke Volume ; Ventricular Function, Left

المؤلفون: Smeele PJ; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Vermunt L; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Blok S; Department of Pulmonary Medicine, Amsterdam University Medical Centre, Amsterdam 1081 HV, the Netherlands., Duitman JW; Department of Pulmonary Medicine, Amsterdam University Medical Centre, Amsterdam 1081 HV, the Netherlands., Nossent EJ; Department of Pulmonary Medicine, Amsterdam University Medical Centre, Amsterdam 1081 HV, the Netherlands., van Agtmael MA; Department of Internal Medicine, Amsterdam University Medical Centre, Amsterdam 1081 HV, the Netherlands., Heunks LMA; Department of Intensive Care Medicine, Amsterdam University Medical Centre, Amsterdam 1081 HV, the Netherlands., Horn J; Department of Intensive Care Medicine, Amsterdam University Medical Centre, Amsterdam 1081 HV, the Netherlands., Bogaard HJ; Department of Pulmonary Medicine, Amsterdam University Medical Centre, Amsterdam 1081 HV, the Netherlands., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

مؤلفون مشاركون: AmsterdamUMC COVID-19 Biobank

المصدر: Brain communications [Brain Commun] 2022 Jul 26; Vol. 4 (4), pp. fcac195. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE

المؤلفون: Duijvelaar E; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Schippers JR; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Smeele PJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., de Raaf MA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Vanhove ALEM; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Blok SG; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Twisk JWR; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Vonk Noordegraaf A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., de Man FS; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Bogaard HJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Aman J; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands. Electronic address: j.aman@amsterdamumc.nl.

مؤلفون مشاركون: CounterCOVID Collaborative Group

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2022 Apr; Vol. 10 (4), pp. e34-e35. Date of Electronic Publication: 2022 Feb 17.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , COVID-19 Drug Treatment*, Follow-Up Studies ; Humans ; Imatinib Mesylate/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Treatment Outcome

المؤلفون: Aman J; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Duijvelaar E; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Botros L; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Kianzad A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Schippers JR; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Smeele PJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Azhang S; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Pulmonology, Haaglanden Medisch Centrum, The Hague, Netherlands., Bartelink IH; Department of Pharmacy, Amsterdam UMC, VUMC, Amsterdam, Netherlands., Bayoumy AA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Pulmonology, Chest Unit, Suez Canal University, Suez, Egypt., Bet PM; Department of Pharmacy, Amsterdam UMC, VUMC, Amsterdam, Netherlands., Boersma W; Department of Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands., Bonta PI; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., Boomars KAT; Department of Pulmonology, Erasmus Medisch Centrum, Rotterdam, Netherlands., Bos LDJ; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands., van Bragt JJMH; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., Braunstahl GJ; Department of Pulmonology, Sint Franciscus Ziekenhuis, Rotterdam, Netherlands., Celant LR; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Eger KAB; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., Geelhoed JJM; Department of Pulmonology Leiden University Medical Center, Leiden, Netherlands., van Glabbeek YLE; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Grotjohan HP; Department of Pulmonology, Isala Ziekenhuizen, Zwolle, Netherlands., Hagens LA; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands., Happe CM; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Hazes BD; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Heunks LMA; Department of Intensive Care, Amsterdam UMC, VUMC, Amsterdam, Netherlands., van den Heuvel M; Department of Pulmonology, Radboud UMC, Nijmegen, Netherlands., Hoefsloot W; Department of Pulmonology, Radboud UMC, Nijmegen, Netherlands., Hoek RJA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Hoekstra R; Department of Pulmonology, Antonius Ziekenhuis, Sneek, Netherlands., Hofstee HMA; Department of Internal Medicine, Haaglanden Medisch Centrum, The Hague, Netherlands., Juffermans NP; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands; Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands., Kemper EM; Hospital Pharmacy, Amsterdam UMC, AMC, Amsterdam, Netherlands., Kos R; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., Kunst PWA; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands., Lammers A; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., van der Lee I; Department of Pulmonology, Spaarne Gasthuis, Haarlem, Netherlands., van der Lee EL; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Maitland-van der Zee AH; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., Mau Asam PFM; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., Mieras A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Muller M; Department of Pulmonology, Catharina Ziekenhuis, Eindhoven, Netherlands., Neefjes ECW; Department of Pulmonology, Catharina Ziekenhuis, Eindhoven, Netherlands., Nossent EJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Oswald LMA; Department of Pulmonology, Sint Franciscus Ziekenhuis, Rotterdam, Netherlands., Overbeek MJ; Department of Pulmonology, Haaglanden Medisch Centrum, The Hague, Netherlands., Pamplona CC; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Paternotte N; Department of Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands., Pronk N; Department of Pulmonology, Gelre Ziekenhuis, Apeldoorn, Netherlands., de Raaf MA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., van Raaij BFM; Department of Pulmonology Leiden University Medical Center, Leiden, Netherlands., Reijrink M; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Schultz MJ; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands., Serpa Neto A; Department of Critical Care Medicine and Institute of Education and Research, Hospital Israelita Albert Einstein, São Paulo, Brazil., Slob EMA; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands., Smeenk FWJM; Department of Pulmonology, Catharina Ziekenhuis, Eindhoven, Netherlands., Smit MR; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands., Smits AJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Stalenhoef JE; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands., Tuinman PR; Department of Intensive Care, Amsterdam UMC, VUMC, Amsterdam, Netherlands., Vanhove ALEM; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Wessels JN; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., van Wezenbeek JCC; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Vonk Noordegraaf A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., de Man FS; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Bogaard HJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. Electronic address: hj.bogaard@amsterdamumc.nl.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Sep; Vol. 9 (9), pp. 957-968. Date of Electronic Publication: 2021 Jun 18.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19/*therapy , Imatinib Mesylate/*administration & dosage , Protein Kinase Inhibitors/*administration & dosage , Respiration, Artificial/*statistics & numerical data , Respiratory Insufficiency/*therapy, Aged ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19/virology ; Capillary Permeability/drug effects ; Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Double-Blind Method ; Female ; Humans ; Imatinib Mesylate/adverse effects ; Male ; Middle Aged ; Netherlands ; Oxygen/administration & dosage ; Placebos/administration & dosage ; Placebos/adverse effects ; Protein Kinase Inhibitors/adverse effects ; Respiratory Insufficiency/diagnosis ; Respiratory Insufficiency/virology ; SARS-CoV-2/isolation & purification ; Severity of Illness Index ; Time Factors ; Treatment Outcome